In-house Advanced Patented Generics Pipeline

About Laxxon Medical

Laxxon Medical is a private, pre-revenue biotech firm developing a novel additive manufacturing platform (SPID®-Technology) for creating advanced oral dosage forms. Its business model focuses on three commercial solutions: patent extension for existing drugs, development of advanced patented generics, and new drug development, primarily leveraging the FDA's 505(b)(2) regulatory pathway. With a pipeline of 13 in-house assets and 4+ external projects, the company aims to capitalize on the impending patent cliff affecting over $100B in drug sales over the next decade.